COMPONENT 2
Clinical Preventive Services
and Health Promotion
Each component is structured into domains, which include topic areas and illustrative examples.
1. Screening
|
Topic Areas
A. Analysis of screening tests
|
Illustrative Examples
Range of normal, sensitivity, specificity, predictive value, target population
|
B. Assessment of health risks
|
Psychosocial factors, environmental factors, genetic determinants
|
C. Criteria for successful screening
|
Effectiveness, benefits and harms, barriers, cost, acceptance by patient
|
D. Clinician‐patient communication
|
Patient participation in decision‐making, informed consent, risk communication, advocacy, health literacy
|
E. Evidence‐based recommendations
|
Use of evidence-based recommendations such as those of the US Preventive Services Task Force
|
F. Government requirements
|
Newborn screening
|
2. Counseling for Behavioral Change
|
A. Approaches to behavior change incorporating diverse patient perspectives
|
Individual and group counseling skills training, motivational interviewing
|
B. Clinician‐patient communication
|
Patient participation in decision making, informed consent, risk communication, advocacy, health literacy
|
C. Criteria for successful counseling
|
Effectiveness, benefits and harms, cost, acceptance by patient
|
D. Evidence‐based recommendations
|
Use of evidence-based recommendations such as those of the US Preventive Services Task Force
|
3. Immunization
|
A. Approaches to vaccination
|
Live vs. attenuated/inactivated vaccine, pre- vs. post-exposure, boosters, techniques for administration, target population, population‐based immunity
|
B. Criteria for successful immunization
|
Effectiveness, benefits and harms, cost, acceptance by patient and community
|
C. Clinician‐patient communication
|
Patient participation in decision‐making, informed consent, risk communication, advocacy, health literacy
|
D. Evidence‐based recommendations
|
Use of evidence-based recommendations such as those of the Advisory Committee on Immunization Practices
|
E. Government requirements
|
State laws, school requirements, vaccine exemptions
|
4. Preventive Medication
|
A. Approaches to chemoprevention
|
Pre- vs. post- exposure, time-limited vs. long-term
|
B. Criteria for successful chemoprevention
|
Effectiveness, benefits and harms, barriers, cost, acceptance by patient
|
C. Clinician‐patient communication
|
Patient participation in decision‐making, informed consent, risk communication, advocacy, health literacy
|
D. Evidence‐based recommendations
|
Use of evidence-based recommendations such as those of the US Preventive Services Task Force
|
5. Other Preventive Interventions
|
A. Lifestyle interventions
|
Diet, exercise, smoking cessation
|
B. Criteria for successful preventive interventions
|
Effectiveness, benefits and harms, barriers, cost, acceptance by patient
|
C. Clinician‐patient communication
|
Patient participation in decision‐making, informed consent, risk communication, advocacy, health literacy
|
D. Evidence‐based recommendations
|
Use of evidence-based recommendations such as those of the U.S. Preventive Services Task Force
|